Risk Factors for MRSA Infection
Prior MRSA infection or colonization is the single strongest risk factor for developing MRSA infection, followed by recent hospitalization, nursing home residence, and recent antibiotic use. 1
Healthcare-Associated Risk Factors
Healthcare exposure remains the predominant risk pathway for MRSA acquisition:
- Prior MRSA infection or colonization within the past year 1, 2
- Recent hospitalization (within previous 1-24 months) 1, 3
- Nursing home or long-term care facility residence 1, 3, 4
- Recent antibiotic exposure (particularly beta-lactams, fluoroquinolones, or macrolides within past 3 months) 1, 3
- Prolonged hospital stay (current duration >16 days) 1
- Presence of invasive devices at time of admission:
- Recent surgery or surgical wounds 5
- Dialysis 1, 2
- Recent outpatient healthcare visits 6
Patient-Specific Risk Factors
Several patient characteristics increase MRSA risk:
- Advanced age (≥75 years) 1
- Chronic comorbidities:
- Pressure ulcers or chronic wounds 5
- Charlson score >5 points 1
Community-Associated Risk Factors
Community-associated MRSA (CA-MRSA) has distinct risk factors:
- Close contact with MRSA-colonized individuals 1, 6
- Living in crowded conditions:
- Participation in contact sports 1, 2
- Injection drug use 1, 2, 6
- Men who have sex with men 1, 2
- Children <2 years old 1, 2
Clinical Risk Factors
Certain clinical presentations increase MRSA risk:
- Severe infection requiring ICU admission 1
- Septic shock 1
- Post-influenza-like illness 1, 2
- Concurrent skin and soft tissue infection 1, 2
Geographic Considerations
- Local MRSA prevalence is important - empiric MRSA coverage is recommended when local prevalence exceeds 20% of S. aureus isolates 1, 2
- Residence in areas with high MRSA circulation 1
Common Pitfalls in MRSA Risk Assessment
Failure to recognize healthcare-associated MRSA in outpatients: Many "community" MRSA cases actually have healthcare risk factors.
Overlooking prior colonization: Previous MRSA colonization is one of the strongest predictors of subsequent infection.
Underestimating the importance of local epidemiology: Local prevalence rates should guide empiric therapy decisions.
Neglecting device-related risks: Invasive devices significantly increase MRSA risk and should prompt consideration of empiric MRSA coverage.
Assuming all MRSA strains are healthcare-associated: CA-MRSA strains have distinct epidemiology and often affect otherwise healthy individuals without traditional healthcare risk factors.
Understanding these risk factors allows for appropriate infection control measures, targeted surveillance, and judicious use of anti-MRSA antibiotics to both treat infections effectively and practice good antimicrobial stewardship.